The effect of different treatments for early lactation hyperketonemia on blood β-hydroxybutyrate, plasma non-esterified fatty acids, glucose, insulin, and glucagon in dairy cattle

Authors

  • S. Mann Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853
  • F. A. Leal Yepes Department of Animal Science, Cornell University, Ithaca, NY 14853
  • E. Behling-Kelly Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853
  • J. A. A. McArt Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853

DOI:

https://doi.org/10.21423/aabppro20173330

Keywords:

metabolic disorders, transition cows, hyperketonemia, glucose, propylene glycol, BHB, β-hydroxybutyrate, dairy cows

Abstract

Despite increased efforts in preventing the occurrence of metabolic disorders in transition cows, hyperketonemia remains a frequent early lactation metabolic disease affecting an average of 40% of cows in herds in the US. Despite the demonstrated economic impact of this disorder there is a lack of controlled clinical trials comparing different treatment strategies in affected cows. The objective of our study was to investigate the effect of treatment with intravenous glucose, oral propylene glycol (PG), or a combination of both on the reduction in blood β-hydroxybutyrate (BHB) concentrations of early lactation hyperketonemic dairy cows.

Cover image of the 50th Conference Proceedings: Text of "AABP Annual Conference" with the AABP logo superimposed over an interlocking 50. Yellow background.

Downloads

Published

2017-09-14

Issue

2017

Section

Research Summaries

Most read articles by the same author(s)

1 2 3 4 > >>